Abstract
OBJECTIVE
This study presents a nationwide cohort description of individuals with diabetes attending a state-authorized podiatrist in Denmark.
RESEARCH DESIGN AND METHODS
This study used data from the Danish Foot Status Database, which contains data on individuals with diabetes attending annual consultations with state-authorized podiatrists. Individuals were identified via their unique central person register number. Data were collected from initiation of the database in September 2015 until 23 June 2025. Data were collected and presented from the individual’s first annual consultation with a state-authorized podiatrist.
RESULTS
The Danish Foot Status Database includes 1,104,889 unique entries from 241,599 individuals with diabetes. Of individuals attending their first consultation with a state-authorized podiatrist, 43% were male and 6.0% had type 1 diabetes, and the median diabetes duration was 2 years. Neuropathy assessed by biothesiometry >25 V was present in 48%; 12% had absent pedal pulse in the arteria dorsalis pedis, 19% had absent pulse in the arteria tibialis posterior, and 91% had at least one malalignment of the foot. Current diabetic foot ulcer was recorded in 4.2%, prior diabetic foot ulcer in 2.7%, and amputation in 0.5%.
CONCLUSIONS
This cohort description outlines foot health on a Danish nationwide level among individuals with diabetes. The Danish Foot Status Database offers valuable data and a unique foundation for future research due to extensive clinical detail on a nationwide population.
Graphical Abstract

Introduction
Foot complications are among the most serious and costly consequences of diabetes, with diabetic foot ulcers (DFUs) affecting up to one-third of individuals with diabetes during their lifetime (1,2). DFUs are associated with increased pain, impaired mobility, and reduced quality of life (3). The 5-year mortality following a DFU is ∼31% and rises to 57% following an above-ankle amputation (1). Worldwide, a lower-limb amputation is performed due to diabetes every 30 s (4).
Neuropathy and peripheral artery disease (PAD) are classically cited as the main risk factors for DFU development. Other complications, such as Charcot foot and foot deformities, increase the risk of ulceration and amputation as well (5,6). Despite the severity of these complications, many DFUs are thought to be preventable through early identification and intervention (7).
The International Working Group on the Diabetic Foot (IWGDF) guidelines recommend annual foot screening for all individuals with diabetes (8). The IWGDF found insufficient evidence that screening alone can prevent the first DFU; however, annual foot screening is still recommended. One of the drivers for the suggested annual screenings was the findings from a meta-analysis of three randomized controlled trials showing that individuals with diabetes attending specialized foot care had significantly fewer ulcer recurrences (8). In Denmark, foot screenings of the ∼368,000 individuals with diabetes (9) are conducted either by a general practitioner, at a specialized diabetes outpatient clinic, or by a state-authorized podiatrist, the latter being partially reimbursed and including an evaluation of neuropathy, PAD, foot deformities, previous and current ulcers, and amputation status. Data from consultations with a state-authorized podiatrist are systematically collected and stored in the Danish Foot Status Database, which provides nationwide coverage. Nevertheless, there is a lack of large cohort studies characterizing foot health among individuals with diabetes in the existing literature.
This study aims to provide a comprehensive cohort description of individuals with diabetes included in the Danish Foot Status Database at their first annual consultation with a state-authorized podiatrist. We present demographic and clinical characteristics and the prevalence of foot complications.
Research Design and Methods
Study Design and Setting
This nationwide cohort description used data from the Danish Foot Status Database, which includes individuals with diabetes attending annual consultations with state-authorized podiatrists in Denmark. For this cohort description, data were collected from the initiation of the database in September 2015 until 30 June 2025. This cohort description presents the cohort at baseline, defined as the individual’s first annual consultation with a state-authorized podiatrist.
Individuals were identified via their unique central person register number. In Denmark, the central person register number is given at birth or immigration (10) and is included in all Danish nationwide administrative registers, making linkage possible.
Study Population
Inclusion Criteria
For the cohort description, adult individuals (≥18 years of age) with diabetes who were recorded in the Danish Foot Status Database were included. Individuals with missing or invalid central person register numbers were excluded. A detailed overview of inclusion and exclusion criteria is provided in Supplementary Fig. 1.
Data Source
The Danish Foot Status Database is technically maintained and hosted by the private company MultiMed and jointly owned by the Association of Danish Podiatrists and Danish Regions. For this study, data extraction from the Danish Foot Status Database was approved by the Record Data Team, Center for Health, and data were transferred to secure servers at the research environment at Statistics Denmark, a public, national statistical institute in Denmark. The Association of Danish Podiatrists is an advocacy organization representing >2,000 state-authorized podiatrists (operating within the primary health care sector), while Danish Regions is the national body responsible for hospitals and health care services in Denmark. All state-authorized podiatrists have completed formal training and certification. During the annual consultation, state-authorized podiatrists collect standardized clinical data. To ensure consistency, a comprehensive instructional manual is used to standardize examinations (see the Supplementary Material for the full manual).
To attend an annual consultation with a state-authorized podiatrist, a referral from a physician (most often the general practitioner) must be provided. For referrals, information on diabetes type, diagnosis year, impaired vision, and chronic kidney disease (CKD) are encouraged to be reported to the state-authorized podiatrist, but it is not mandatory. As described in the manual, the state-authorized podiatrist is obliged to ask the individual about this information and subsequently collect documentation from relevant physicians. Only state-authorized podiatrists, with a referral from the individual’s general practitioner, can upload to the database.
Data are documented contemporaneously in the patient record, after which the podiatrists’ information technology system transmits the foot status assessment to the Danish Foot Status Database. At initiation of the database in 2015, state-authorized podiatrists could upload data from prior consultations. This is reflected in the data where some consultations are dated prior to 2015; these data are not presented in this cohort description.
The database was updated in September 2023, introducing systematic data collection, mandatory completion of key fields, and additional variables, including amputation due to diabetes (see Supplementary Table 1 for a complete list of variables before and after the update). Prior to the update in 2023, data from the earlier consultations were uploaded by designated external companies following a data guideline with few specifications, resulting in most systems only uploading values that deviated from the norm. Following the update, all data are now systematically uploaded to the database. Additionally, the interface was modified so that the annual screening form cannot be submitted unless all required fields are completed, thereby reducing missing values.
Variables
For the presentations in this cohort description, all characteristics of the cohort were recorded at the time of the unique individual’s first annual consultation at a state- authorized podiatrist (baseline). Demographic variables included age and sex. As these variables are not recorded directly in the database, information was obtained through linkage to the Danish Civil Registration System using the central person register number, with age and sex defined at the time of the first annual consultation registered in the database. Clinical variables included in this cohort description were diabetes type, date of diabetes diagnosis, CKD, impaired vision, neuropathy, PAD, palpable pulses (arteria dorsalis pedis and arteria tibialis posterior), toe blood pressure (TBP), edema, malalignment, prior and current DFU, and prior amputation.
Individuals with diabetes were recorded as having either type 1 diabetes, type 2 diabetes, or other diabetes types. In the database interface, podiatrists can mark diabetes type as either type 1 diabetes or type 2 diabetes. According to the guidelines for state-authorized podiatrists, less common forms of diabetes, such as maturity-onset diabetes of the young and latent autoimmune diabetes of adults, were recorded as type 2 diabetes. In cases where podiatrists had entered free-text comments (before the 2023 update), data were manually reviewed, and diabetes type was recorded into three categories: type 1 diabetes, type 2 diabetes, or other.
The variables status and foot status were also included in this cohort description. The variable status is the podiatrist classification of foot risk (e.g., low, moderate, high), which is used to determine the recommended frequency of future consultations with state-authorized podiatrists. The variable foot status indicates whether the condition of the foot has improved, has deteriorated, or is unchanged since the previous assessment or whether this consultation is the first with a state-authorized podiatrist. Some variables were merged for analysis; for example, arteria dorsalis pedis was registered separately for the right and left foot in the database but is presented here as one variable. Arteria dorsalis pedis was coded as no pulse if at least one was registered as no pulse. Years since diagnosis was calculated from the recorded date of diagnosis and rounded to nearest full year. Biothesiometer measurements are presented as measured, and a new variable was added as neuropathy diagnosed by biothesiometer, where the neuropathy outcome is set with a cutoff at ≥25 V.
Statistical Analysis
Descriptive statistics were used to summarize the baseline characteristics of the cohort. Normality in the continuous variables were assessed by visual inspection of histograms. They are presented as medians with interquartile ranges (IQRs). Categorical variables are presented as counts and percentages. Age <0 and >120 years were coded as missing. All missing data are presented as counts. For this study, data were extracted from the Danish Foot Status Database and transferred to the secure servers at Statistics Denmark for data management, and statistical analyses were conducted using R statistical software (11).
Ethics
According to the Danish Data Protection Act and the General Data Protection Regulation, studies of this type do not require ethical approval or patient informed consent. The study has been reported and approved by Privacy, the data-responsible institute in the Capital Region of Denmark. Approval to obtain recorded data from the Danish Foot Status Database was granted by the Record Data Team, Center for Health, the institute responsible for clinical and administrative health data in the Capital Region of Denmark.
Data and Resource Availability
The Danish Foot Status Database is jointly owned by the Association of Danish Podiatrists and Danish Regions. Access to data requires approval from Privacy, the data-responsible institute in the Capital Region of Denmark and by the Record Data Team, Center for Health, in the Capital Region of Denmark. All data were accessed within the secure research environment of Statistics Denmark, where multiple registries can be linked but individual-level data cannot be exported. All personal information is encrypted, and data sets cannot be made publicly available due to Danish legislation. Researchers interested in accessing the data must apply for approval from the relevant authorities mentioned above and are welcome to contact the authors to discuss potential collaboration on future studies.
Results
Data Scope and Coverage
A total of 1,105,853 entries were recorded in the Danish Foot Status Database from September 2015 to June 2025. After excluding 157 entries with invalid central person register numbers and 807 entries from individuals <18 years of age, the final cohort comprised 241,599 unique individuals with diabetes, represented by 1,104,889 valid entries (Fig. 1).
Figure 1.

Flowchart of included entries into the Danish Foot Status Database. CPR, central patient register.
Prior to the September 2023 database update, 211,661 unique individuals were recorded, while 154,018 unique individuals were recorded after the update. Among these, 124,678 individuals appear in both data sets. An additional 29,332 individuals were only present in the data set after the update, and 86,978 were only present in the data set before the update.
In 2024, 127,131 individuals attended an annual consultation with a state-authorized podiatrist. The median number of visits at a state-authorized podiatrist from 2015 to 2024 was 4 (IQR 2, 7). The distribution of visits is presented in Supplementary Fig. 1. The number of unique individuals attending a state-authorized podiatrist for the annual consultation during the years of database operation is presented in Fig. 2.
Figure 2.

Number of annual consultations at a state-authorized podiatrist per year in Denmark. Dark blue represents unique individuals’ first annual visit at a state-authorized podiatrist, and light blue represents unique individual second or later annual visit at a state-authorized podiatrist. The red line indicates the time of the database update in September 2023.
Baseline Characteristics of the Population
Baseline characteristics of the individuals at the first annual consultation with a state-authorized podiatrist are presented in Table 1. Before the update, 45% of individuals were male and 55% female compared with 43% male and 58% female after the update. Type 1 diabetes was recorded in 10% of individuals before the update and 6% after, while type 2 diabetes was recorded in 90% and 94%, respectively. Median years since diagnosis was 6 years before the update and 2 years after. Of those reported with CKD status, CKD was registered in 10% of individuals before the update and 3% after. Impaired vision was not reported in any individuals in the data set before the update, but in 25% after the update.
Table 1.
Patient baseline characteristics at first annual consult with a state-authorized podiatrist
| Variable | Before update (2015–2023) (n = 211,656) | After update (2023) (n = 29,333) |
|---|---|---|
| Sex, n (%) | ||
| Male | 95,652 (45.2) | 12,467 (42.5) |
| Female | 116,004 (54.8) | 16,866 (57.5) |
| Age, median (IQR), years | 67 (58, 75) | 65 (56, 74) |
| Diabetes type, n (%) | ||
| Type 1 | 20,411 (9.7) | 1,773 (6.0) |
| Type 2 | 190,491 (90.3) | 27,560 (94.0) |
| Other | 0 (0) | 0 (0) |
| Missing | 753 | 0 |
| Years since diagnosis, median (IQR) | 6 (2, 14) | 2 (0, 8) |
| Missing | 2,110 | 35 |
| CKD, n (%) | ||
| No | 83,482 (89.6) | 21,452 (73.1) |
| Yes | 9,691 (10.4) | 917 (3.1) |
| Not reported | 0 (0) | 6,964 (23.7) |
| Missing | 118,483 | 0 |
| Impaired vision, n (%) | ||
| No | 81,459 (84.1) | 21,068 (71.8) |
| Yes | 0 (0) | 7,323 (25.0) |
| Not reported | 15,364 (15.9) | 942 (3.2) |
| Missing | 114,833 | 0 |
Percentages were calculated among individuals with available recordings for the variables.
Foot Examination: Neuropathy, PAD, and Malalignments
Key variables at individuals’ first annual consultation at a state-authorized podiatrist are presented in Table 2, with percentages calculated among individuals with available recordings for the variables. Neuropathy assessed by biothesiometer was present in 52% of individuals before the update and 48% after the update. Absence of pulse was recorded in 47% for arteria dorsalis pedis and 45% for arteria tibialis posterior before the update compared with 12% and 19%, respectively, after the update. TBP was reported as no, meaning not done or not reported, in 98% before the update and 0.6% after but was reported as not reported/measured in 99% after the update. Edema was present in 60% before the update and 26% after, while malalignment was recorded in 94% and 91%, respectively. For further data on neuropathy, PAD, and malalignment examinations, see Supplementary Tables 2–4.
Table 2.
Key variables at first annual consultation with state-authorized podiatrist
| Variable | Before update (2015–2023) (n = 211,656) | After update (2023) (n = 29,333) |
|---|---|---|
| Neuropathy assessed by biothesiometry, n (%) | ||
| No neuropathy | 101,757 (48.5) | 15,342 (52.3) |
| Neuropathy | 108,265 (51.5) | 13,971 (47.7) |
| Missing | 1,634 | 20 |
| Arteria dorsalis pedis, n (%) | ||
| Pulse | 56,386 (53.0) | 25,808 (88.1) |
| No pulse | 50,034 (47.0) | 3,475 (11.9) |
| Missing | 105,236 | 50 |
| Arteria tibialis posterior, n (%) | ||
| Pulse | 53,165 (45.3) | 23,612 (80.6) |
| No pulse | 64,314 (54.7) | 5,677 (19.4) |
| Missing | 94,177 | 44 |
| TBP, n (%) | ||
| NR/not measured | NR | 29,064 (99.1) |
| No | 75,684 (97.7) | 181 (0.6) |
| Yes | 1,788 (2.3) | NR |
| 0–30 mmHg | NR | 37 (0.1) |
| >30 mmHg | NR | 50 (0.2) |
| Missing | 134,184 | 0 |
| Edema, n (%) | ||
| No | 51,273 (40.0) | 21,578 (73.7) |
| Yes | 76,768 (60.0) | 7,708 (26.3) |
| Missing | 83,615 | 47 |
| Malalignment, n (%) | ||
| Yes | 179,819 (94.3) | 26,580 (90.7) |
| No | 10,852 (5.7) | 2,735 (9.3) |
| Missing | 20,985 | 18 |
| Current foot ulcer, n (%) | ||
| Yes | 8,407 (9.2) | 1,229 (4.2) |
| No | 83,410 (90.8) | 28,046 (95.8) |
| Missing | 119,839 | 58 |
| Prior foot ulcer, n (%) | ||
| Yes | 12,513 (13.1) | 757 (2.6) |
| No | 82,685 (86.9) | 28,514 (97.4) |
| Missing | 116,458 | 62 |
| Amputation due to diabetes, n (%) | ||
| Yes | NR | 152 (0.5) |
| No | NR | 29,010 (99.5) |
| Missing | NR | 171 |
| Status, n (%)* | ||
| 1 | 1,470 (0.7) | 200 (0.7) |
| 2 | 131,478 (62.1) | 22,129 (75.4) |
| 3 | 67,671 (32.0) | 5,555 (18.9) |
| 4 | 11,037 (5.2) | 1,449 (4.9) |
| Foot status, n (%) | ||
| Unchanged | 14,425 (6.9) | 153 (0.5) |
| Improved | 112,016 (53.6) | 28,495 (97.1) |
| Deteriorated | 6,976 (3.3) | 96 (0.3) |
| First consultation | 75,628 (36.2) | 589 (2.0) |
| Missing | 2,611 | 0 |
Percentages are calculated among individuals with available recordings for the variables. NR, not reported.
*Status is the state-authorized own risk scoring system used to determine frequency of podiatric care for the individual.
Foot Examination: DFUs and Amputations
Current foot ulcers at the first annual consultation with a state-authorized podiatrist were recorded in 9% of individuals before the update and 4% after the update. The classification of the ulcers can be seen in Supplementary Table 5. Previous foot ulcers at the first available visit were recorded in 13% and 3%, respectively. The location and percentages can be seen in Supplementary Fig. 2. Amputation due to diabetes was reported in 0.5% of individuals after the update. The possibility to register amputation due to diabetes was added in the 2023 update and therefore not registered before the update. Amputation site and prevalence can be seen in Supplementary Fig. 3.
Conclusions
The Danish Foot Status Database constitutes a nationwide clinical database based on annual consultations at a state-authorized podiatrist, enabling a comprehensive overview of foot health among adults with diabetes attending podiatric care. Such nationwide data are rarely available and provide a robust foundation for epidemiological research, clinical quality improvement, and health policy development.
Although the cohort only represents individuals attending state-authorized podiatric care, it spans all stages of foot health. The mechanisms underlying diabetic foot complications are universal, making these findings relevant beyond Denmark and informative for international preventive strategies.
This cohort description introduces the Danish Foot Status Database and outlines the characteristics of individuals with diabetes attending consultations at state-authorized podiatrists in Denmark. The database update in September 2023 led to significantly improved data completeness and quality.
Baseline characteristics differed between the periods before and after the update, reflecting improved reporting and more complete capture of relevant variables rather than true changes in population health. Individuals registered with a first visit before the update likely consulted a state-authorized podiatrist prior to initiation of the database, which may have resulted in a longer time since diagnosis, higher prevalence of comorbidities, and a higher prevalence of foot complication when accessing data before the update, whereas individuals after the update likely represent a more reliable picture of the first visit at a state-authorized podiatrist. Impaired vision before the update had none registered as yes. This is likely a reflection on data collection and data management rather than a true prevalence of impaired vision among individuals with diabetes. Both CKD and impaired vision status are reported by the referring physician (most often the general practitioner) and are not mandatory at referral. State-authorized podiatrists can enter these data only if supported by documentation from the referring physician. After the update, reporting this information is still not mandatory, but missing data have decreased substantially. The low prevalence of CKD compared with other studies (12) might be due to underreporting, as shown by a high number of not reported and by the relatively short duration of diabetes when first attending an annual consultation at a state-authorized podiatrist.
Key predictors of DFU, including neuropathy, PAD, and malalignments, also changed after the update. Neuropathy diagnosed by biothesiometer was slightly lower after the update, whereas the proportion of missing data decreased substantially. The recorded prevalence of absence of pulse in the arteria dorsalis pedis and arteria tibialis posterior was markedly lower after the update but with a low proportion of TBP measurements. This might reflect an issue with lack of a timely diagnosis of PAD or a communication issue between the primary and secondary sectors. Malalignments remained highly prevalent in both periods, with only minor differences between data before and after the update. These observations highlight the value of a standardized database in capturing a more accurate and complete picture of foot complications while emphasizing that apparent differences may reflect documentation rather than true shifts in disease burden.
The prevalence of current DFU at first consultation was 9.2% before the update compared with 4.2% after, while the prevalence of previous DFU was 13% and 2.7%, respectively. A possible reason for the difference in prevalence before and after the update might be explained by data management prior to the update and the population before the update not being a true first consultation with a state-authorized podiatrist. Before the update, data uploaders had only a data guideline with few specifications, resulting in most data uploaders only uploading values that deviated from the norm, and an error was identified in one of the systems’ transmission of foot pulse data, which could have led to overreporting of several variables, including absence of pedal pulses and DFUs.
The main challenge of DFUs is that they can lead to infections and amputations. McDermott et al. (2) found that 20% of DFU treatments end in a lower-limb amputation. This contrasts the prevalence of amputation reported in this cohort description. Amputation due to diabetes was recorded in 0.5% of individuals after the update. The low prevalence of amputation in this cohort might reflect a lack of reporting in the Danish Foot Status Database or overreporting in other studies and registers. It can also be reflected by the cohort, which included a broader spectrum of individuals with diabetes, where many are seen by a state-authorized podiatrist relatively early after the initial diagnosis of diabetes, which may contribute to the low prevalence of amputations in this cohort. Part of the explanation for the low prevalence could also be that individuals with an amputation are managed in other clinical settings, i.e., specialized clinics at hospitals. Previous studies have shown that mortality following an amputation is high (1) and that individuals isolate themselves following an amputation (13) and may therefore not prioritize foot screening and podiatric care. In addition, it has been shown that there is a strong correlation between lower social status and risk of amputation (5), perhaps leading to monetary considerations hindering podiatric care.
The baseline characteristics of individuals with type 2 diabetes in the Danish Foot Status Database after the update differs in characteristics from larger cohorts in other countries (14,15). The Seattle Diabetic Foot Study included 749 individuals with diabetes, with each lower limb (n = 1,483) described separately (14), and the European Study Group on Diabetes and the Lower Extremity (EURODIALE) study included 1,088 individuals with diabetes who had a DFU (15). Individuals in this cohort were predominantly female and had a comparably shorter duration of diabetes, though they were comparable in age to individuals in the Seattle Diabetic Foot Study and EURODIALE cohorts. The prevalence of neuropathy, PAD, CKD, and impaired vision in the Danish Foot Status Database is generally not comparable to the Seattle Diabetic Foot Study or EURODIALE cohorts, possibly due to the Danish Foot Status Database including a larger cohort spanning a nationwide, broader range of individuals across all stages of foot health and with a shorter duration of diabetes. The prevalence of DFUs and amputations widely differs from the other cohorts. Differences in baseline characteristics, complication prevalence, DFUs, and amputations likely reflect variations in cohort selection, population heterogeneity, and data collection methods rather than true differences in disease prevalence.
Based on an estimated 368,000 individuals with diabetes in Denmark in 2024 (9), ∼34% attended an annual consultation at a state-authorized podiatrist in 2024. Interestingly, the population in our database is predominantly women, despite diabetes being more prevalent among men in Denmark (type 2 diabetes: 46% women, 54% men; type 1 diabetes: 43% women, 57% men [9]), which may indicate that women are more compliant in seeking podiatric care, even in a health care system like Denmark's, where a state-authorized podiatry service is available nationwide and cofinanced by the state. Overall, the Danish Foot Status Database can be a valuable resource for identifying high-risk populations, informing preventive interventions, and ultimately reducing morbidity and mortality and improving outcomes for people with diabetes.
Strengths and Limitations
The Danish Foot Status Database is rich in clinical detail with standardized assessments. This level of detail provides a strong foundation for future epidemiological and health services research. The database spans nationwide, and the comprehensive registration selection bias of individuals with diabetes is limited and ensures representativeness across regions. The database has high data completeness after the update in 2023, with few missing data. Another strength is that the database was established to support podiatric clinical work rather than for research purposes; thus, the data collected are clinically relevant for podiatric care. However, since the database was not designed to answer a specific research hypothesis, this may also represent a limitation from a research perspective. The use of the unique central person register numbers enables linkage with other Danish nationwide registries, allowing for future studies on long-term follow-up and enrichment with a multitude of additional variables, such as comorbidities, prescriptions, and mortality.
Several limitations should be acknowledged. Some variables, such as diabetes duration, CKD, impaired vision, and TBP, are reported by the referring physician. If these data are not included in the referral, the state-authorized podiatrist is instructed to ask the individual and collect documentation of their response from the referring physician or register it as not reported. Linkage with national registries may help address some of these gaps in future research. Even though podiatrists follow standardized examination guidelines, differences in assessment or interpretation may occur, particularly in areas requiring subjective clinical judgments. However, such variations can be assumed to be random rather than systematically biased.
The database only includes annual consultations performed by state-authorized podiatrists, excluding those conducted by nonauthorized practitioners. Individuals with diabetes receive partial state reimbursement only when consulting a state-authorized podiatrist, which provides a strong incentive to use state-authorized podiatrists.
Considerations when using the Danish Foot Status Database should be taken, as some individuals with severe diabetic foot complications are treated in specialized hospital wound clinics or primary wound clinics, which do not report to the Danish Foot Status Database. The size of this group is currently unknown, but it may partly explain the relatively low prevalence of active ulcers and amputations in our study cohort.
The database does not capture the entire population of individuals with diabetes in Denmark. While the factors mentioned above may account for some of this, they are unlikely to explain it fully. We believe there is a group of individuals who do not attend either state-authorized podiatrists or specialized wound centers. Possible explanations include the required partial copayment or a lack of perceived relevance due to limited education or awareness about proper foot care.
Generalizability
Studies conducted using the Danish Foot Status Database are likely generalizable to adults with diabetes in health care systems offering structured preventive foot care. The database includes ∼34% of all individuals with diabetes in Denmark (2024), spanning all geographical areas of Denmark and a wide range of patient demographics, diabetes type, and diabetes duration. This nationwide scope enhances representativeness and reflects real-world practice in a publicly funded system.
Despite differences in health care structures, the mechanisms behind diabetic foot complications are universal. Findings from studies including the Danish Foot Status Database can inform prevention and management strategies in diverse settings, and the database offers a valuable model for countries aiming to improve diabetic foot surveillance and long-term outcomes.
This article contains supplementary material online at https://doi.org/10.2337/figshare.31937313.
Article Information
Acknowledgments
The authors thank their colleagues, including the state-authorized podiatrists, who contributed data to the Danish Foot Status Database, without whom this study would not have been possible. They also extend sincere gratitude to all the individuals attending a state-authorized podiatrist, whose data contributions made this research possible. Fig. 1 and Supplementary Figs. 2 and 3 were created in BioRender (biorender.com).
Funding
This study was supported by the Vissing Foundation, the Danish Wound Healing Society, and North Zealand Hospital.
Duality of Interest
C.Y.B. is employed by the Association of Danish Podiatrists. M.B.B. is a board member of the Association of Danish Podiatrists and the Danish Wound Healing Society. S.N.S. is chairman of the board for the Association of Danish Podiatrists. J.A.A. is a board member of the Danish Wound Healing Society, is a member of the IWGDF Prevention Working Group, and has received honoraria from talks given in collaboration with Juzo and Novo Nordisk. None of the authors are associated or affiliated with MultiMed. No other potential conflicts of interest relevant to this article were reported.
Author Contributions
A.E.O. wrote the first draft of the manuscript. A.E.O., K.K.S., C.S.D., P.D.W.Y., C.Y.B., M.B.B., S.N.S., C.T.-P., B.H., M.P.A., P.L.K., and J.A.A. were involved in the design and conduct of the study and the analysis and interpretation of the results. A.E.O., M.Y.A., S.M., M.P.A., P.L.K., and J.A.A. were involved in the conception of the study. All authors edited, reviewed, and approved the final version of the manuscript. J.A.A. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Prior Presentation
Parts of this study were presented in abstract form at the Danish Wound Healing Association Conference, Odense, Denmark, 20–21 November 2025.
Supporting information
References
- 1. Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res 2020;13:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care 2023;46:209–221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Khunkaew S, Fernandez RS, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis. Qual Life Res 2019;28:1413–1427 [DOI] [PubMed] [Google Scholar]
- 4. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366: 1719–1724 [DOI] [PubMed] [Google Scholar]
- 5. Armstrong DG, Tan T-W, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA 2023;330:62–75 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep 2019;19:86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev 2016;32(Suppl. 1):195–200 [DOI] [PubMed] [Google Scholar]
- 8. Bus SA, Sacco ICN, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev 2024;40:e3651. [DOI] [PubMed] [Google Scholar]
- 9. Sundhedsvæsenets Kvalitetsinstitut . Annual report 2024 from the Danish Diabetes Database, 2025. Accessed 1 April 2026. Available from https://www.sundk.dk/kliniske-kvalitetsdatabaser/dansk-diabetes-database-ddid/nyheder-fra-dansk-diabetes-database-ddid/aarsrapport-2024-fra-dansk-diabetes-database/
- 10. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39:22–25 [DOI] [PubMed] [Google Scholar]
- 11. The R Project for Statistical Computing . R: a language and environment for statistical computing, 2025. Accessed 23 December 2025. Available from https://www.r-project.org/
- 12. Fenta ET, Eshetu HB, Kebede N, et al. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis. Diabetol Metab Syndr 2023;15:245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Jo S-H, Kang S-H, Seo W-S, Koo B-H, Kim H-G, Yun S-H. Psychiatric understanding and treatment of patients with amputations. Yeungnam Univ J Med 2021;38:194–201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036–1042 [DOI] [PubMed] [Google Scholar]
- 15. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008;51: 747–755 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
